New breast cancer Rx gets green light
Note: this article is provided by ONU Healthwise Pharmacy.
The US Food and Drug Administration (FDA) has approved a new medication to treat breast cancer.
This new approval is called Enhertu (fam-trastuzumab deruxtecan-nxki).
The FDA approved Enhertu to treat adults with human epidermal growth factor receptor 2 (HER2)-positive breast cancer that cannot be removed with surgery or has spread to other parts of the body.
HER2-positive breast cancer is aggressive and accounts for an estimated 20 percent of breast cancers, according to the FDA.
Enhertu is meant for adults who have already tried at least two treatments that have targeted HER2. This medication is injected into the vein by your health care provider. It is to be given every three weeks.
"There have been many advances in the development of drugs for HER2-positive breast cancer since the introduction of Herceptin (trastuzumab) in 1998," said Dr. Richard Pazdur, director of the FDA’s Oncology Center of Excellence and acting director of the Office of Oncologic Diseases, in a press release. "The approval of Enhertu represents the newest treatment option for patients who have progressed on available HER2-directed therapies."
Common side effects of Enhertu may include nausea, feeling very tired, vomiting, hair loss, constipation and reduced appetite. This medication comes with a boxed warning (the strongest type of drug warning) regarding a risk of conditions that can lead to scarring and inflammation of lung tissue. Other potentially serious side effects include changes in blood cell counts and heart problems.
This drug may also harm unborn babies. For both men and women, effective birth control is recommended while taking this medication.
The FDA granted approval of this medication to Daiichi Sankyo.
Stories Posted This Week
Friday, June 27, 2025
- Foundation launches Rooted to Rise initiative
- Eight vehicle injury crash IR 75 in Hancock County
- Bluffton Mayor commends Safety Services on June 26 injury accident response
- What's in your weekend?, June 27-28-29
- Go wolfhound to Bluffton
- Letter: Ask for veto of HB 96 library provision
- ODNR Offering Hunter Education Instructor Classes
Thursday, June 26, 2025
- Bluffton safety services respond to multi-vehicle accidents on I-75
- Travel opportunities update from Bluffton Senior Center
- Send July 2025 Community Calendar items to the Icon
- National Night Out is August 5, planning is in final stages
- Bluffton Senior Center activities schedule for July 2025
- Does your business have summer hours? Post them on the Icon
- Bluffton, Ohio ranks 4th in Ohio for bike network quality
Wednesday, June 25, 2025
Tuesday, June 24, 2025
Monday, June 23, 2025
- Anna Marie Beagle taught at Allen East Elementary
- Noteworthy dress rehearsal and concert with potluck in Ada, June 23 and 29
- First Bluffton Art Walk provides a welcome outing on a rainy day
- Hardin County Commissioners send letter objecting to HB 335
- Duckie Cosplay underway at Bluffton Public Library
- Upcoming BPL events, June 23-28